The purpose of this study is to demonstrate that pomalidomide enhances chemosensitization of pancreatic cancer by inhibition of Gem/S1-induced NF-κB activation in vitro and in vivo. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.